Guardian Pharmacy Services Inc
NYSE:GRDN
Balance Sheet
Balance Sheet Decomposition
Guardian Pharmacy Services Inc
Guardian Pharmacy Services Inc
Balance Sheet
Guardian Pharmacy Services Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
6
|
15
|
1
|
1
|
5
|
|
| Cash Equivalents |
0
|
6
|
15
|
1
|
1
|
5
|
|
| Total Receivables |
54
|
49
|
55
|
68
|
77
|
97
|
|
| Accounts Receivables |
51
|
46
|
55
|
68
|
77
|
97
|
|
| Other Receivables |
3
|
3
|
0
|
0
|
0
|
0
|
|
| Inventory |
31
|
32
|
33
|
41
|
37
|
41
|
|
| Other Current Assets |
5
|
7
|
9
|
10
|
15
|
10
|
|
| Total Current Assets |
90
|
94
|
112
|
120
|
130
|
152
|
|
| PP&E Net |
35
|
52
|
52
|
65
|
73
|
79
|
|
| PP&E Gross |
35
|
52
|
52
|
65
|
73
|
79
|
|
| Accumulated Depreciation |
40
|
47
|
54
|
61
|
69
|
78
|
|
| Intangible Assets |
21
|
19
|
17
|
14
|
12
|
15
|
|
| Goodwill |
46
|
52
|
55
|
56
|
56
|
69
|
|
| Other Long-Term Assets |
4
|
1
|
1
|
0
|
0
|
6
|
|
| Other Assets |
46
|
52
|
55
|
56
|
56
|
69
|
|
| Total Assets |
197
N/A
|
218
+11%
|
236
+8%
|
256
+9%
|
271
+6%
|
321
+18%
|
|
| Liabilities | |||||||
| Accounts Payable |
55
|
53
|
65
|
78
|
86
|
102
|
|
| Accrued Liabilities |
15
|
27
|
20
|
19
|
23
|
21
|
|
| Short-Term Debt |
7
|
0
|
0
|
4
|
9
|
0
|
|
| Current Portion of Long-Term Debt |
6
|
6
|
6
|
7
|
8
|
4
|
|
| Other Current Liabilities |
8
|
1
|
20
|
4
|
12
|
17
|
|
| Total Current Liabilities |
90
|
86
|
112
|
112
|
138
|
144
|
|
| Long-Term Debt |
37
|
33
|
29
|
26
|
23
|
3
|
|
| Minority Interest |
28
|
29
|
29
|
33
|
32
|
7
|
|
| Other Liabilities |
12
|
31
|
42
|
42
|
50
|
23
|
|
| Total Liabilities |
167
N/A
|
179
+7%
|
212
+18%
|
213
+1%
|
243
+14%
|
178
-27%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
0
|
17
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
125
|
|
| Other Equity |
29
|
38
|
24
|
43
|
28
|
0
|
|
| Total Equity |
29
N/A
|
38
+31%
|
24
-38%
|
43
+79%
|
28
-34%
|
143
+406%
|
|
| Total Liabilities & Equity |
197
N/A
|
218
+11%
|
236
+8%
|
256
+9%
|
271
+6%
|
321
+18%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
62
|
62
|
62
|
62
|
62
|
63
|
|